The WinSanTor Solution
HOPE FOR NEUROPATHY SUFFERERS
Recent News
This month, Mental Health Awareness Month, we are raising awareness about the mental impact of peripheral neuropathy - and how to manage it.
https://t.co/tH5izNFEpR
#MentalHealthAwarenessMonth #MentalHealthMonth #WinSanTor #PeripheralNeuropathy #blogpost
https://t.co/tH5izNFEpR
#MentalHealthAwarenessMonth #MentalHealthMonth #WinSanTor #PeripheralNeuropathy #blogpost
May 1-8 was National Neuropathy Awareness Week. Help us call attention to this common yet neglected condition.
#PeripheralNeuropathy #WinSanTor #Infographic #HealthAwareness #NationalNeuropathyAwarenessWeek https://t.co/lZVxZDTikW
#PeripheralNeuropathy #WinSanTor #Infographic #HealthAwareness #NationalNeuropathyAwarenessWeek https://t.co/lZVxZDTikW
May 1-8 is National Neuropathy Awareness Week. Help us call attention to this common yet neglected condition: https://t.co/GwE8QraFqd #peripheralneuropathy @FoundationforPN
Investors

WinSanTor Inc. is a private biotechnology company focused on the discovery and development of treatments for peripheral neuropathies. WinSanTor recently completed Phase 1 trials for its lead drug, WST-057, and will begin recruiting for its Phase 2 trials in Canada to treat patients with diabetic peripheral neuropathy.